Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
78.2 GBX | -0.89% | +0.64% | -9.39% |
Summary
- According to Refinitiv, the company's ESG score for its industry is poor.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 7.44 and 7.18 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company is one of the best yield companies with high dividend expectations.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- Based on current prices, the company has particularly high valuation levels.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Residential REITs
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.39% | 617M | D+ | ||
+2.92% | 27.36B | A- | ||
+6.33% | 24.64B | B | ||
+1.99% | 21.31B | B- | ||
+4.78% | 16.68B | B+ | ||
-0.56% | 15.62B | B | ||
-11.72% | 14.71B | C | ||
+0.86% | 12.72B | B | ||
-11.02% | 11.71B | B- | ||
+3.38% | 10.94B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- THRL Stock
- Ratings Target Healthcare REIT PLC